These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 30515172)

  • 21. Comparative in-vitro activity of cefoperazone-tazobactam and cefoperazone-sulbactam combinations against ESBL pathogens in respiratory and urinary infections.
    Patankar M; Sukumaran S; Chhibba A; Nayak U; Sequeira L
    J Assoc Physicians India; 2012 Nov; 60():22-4. PubMed ID: 23767198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients.
    Jones RN
    Am J Med; 1996 Jun; 100(6A):3S-12S. PubMed ID: 8678095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacterial resistance in the new millennium. Its impact on antibiotic selection for respiratory tract infections.
    Appelbaum PC
    Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):5-16. PubMed ID: 19667544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibiotics-Peptide Conjugates Against Multidrug-resistant Bacterial Pathogens.
    David AA; Park SE; Parang K; Tiwari RK
    Curr Top Med Chem; 2018; 18(22):1926-1936. PubMed ID: 30499392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current issues in the management of bacterial respiratory tract disease: the challenge of antibacterial resistance.
    Dunbar LM
    Am J Med Sci; 2003 Dec; 326(6):360-8. PubMed ID: 14671500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of Antibiotic Resistance.
    Munita JM; Arias CA
    Microbiol Spectr; 2016 Apr; 4(2):. PubMed ID: 27227291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging resistance problems among respiratory tract pathogens.
    Lister PD
    Am J Manag Care; 2000 May; 6(8 Suppl):S409-18. PubMed ID: 10977480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. From macrolides to ketolides: What is available for the treatment of outpatient respiratory tract infections?
    Carter PL
    Postgrad Med; 2002 Sep; 112(3 Suppl):18-25. PubMed ID: 19667591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Emergence pathogens infections in ENT Department of Children's hospital in 2005-2008].
    Zielnik-Jurkiewicz B; Rakowska-Szkudlarek M
    Otolaryngol Pol; 2009; 63(6):513-9. PubMed ID: 20198987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial resistance in bacterial pathogens among hospitalized children with community acquired lower respiratory tract infections in Dongguan, China (2011-2016).
    He X; Xie M; Li S; Ye J; Peng Q; Ma Q; Lu X; Zhong B
    BMC Infect Dis; 2017 Sep; 17(1):614. PubMed ID: 28893195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
    Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
    Evid Based Child Health; 2013 Jul; 8(4):1297-371. PubMed ID: 23877944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Microbiological causes of antibiotic therapy failure in respiratory tract infections].
    Kozioł-Montewka M
    Pol Merkur Lekarski; 2011 May; 30(179):373-6. PubMed ID: 21675146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tackling Threats and Future Problems of Multidrug-Resistant Bacteria.
    Medina E; Pieper DH
    Curr Top Microbiol Immunol; 2016; 398():3-33. PubMed ID: 27406189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanomaterials for alternative antibacterial therapy.
    Hemeg HA
    Int J Nanomedicine; 2017; 12():8211-8225. PubMed ID: 29184409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parenteral antibiotic therapy in the treatment of lower respiratory tract infections. Strategies to minimize the development of antibiotic resistance.
    Cazzola M; Matera MG; Noschese P
    Pulm Pharmacol Ther; 2000; 13(6):249-56. PubMed ID: 11061979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High prevalence of multidrug resistant Enterobacteriaceae isolated from outpatient urine samples but not the hospital environment in Bo, Sierra Leone.
    Leski TA; Taitt CR; Bangura U; Stockelman MG; Ansumana R; Cooper WH; Stenger DA; Vora GJ
    BMC Infect Dis; 2016 Apr; 16():167. PubMed ID: 27090787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical resistance encountered in the respiratory surveillance program (RESP) study: a review of the implications for the treatment of community-acquired respiratory tract infections.
    Ehrhardt AF; Russo R
    Am J Med; 2001 Dec; 111 Suppl 9A():30S-35S discussion 36S-38S. PubMed ID: 11755441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Managing acute lower respiratory tract infections in an era of antibacterial resistance.
    Volturo GA; Low DE; Aghababian R
    Am J Emerg Med; 2006 May; 24(3):329-42. PubMed ID: 16635707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2010: General view of the pathogens' antibacterial susceptibility.
    Yanagihara K; Kadota J; Aoki N; Matsumoto T; Yoshida M; Yagisawa M; Oguri T; Sato J; Ogasawara K; Wakamura T; Sunakawa K; Watanabe A; Iwata S; Kaku M; Hanaki H; Ohsaki Y; Watari T; Toyoshima E; Takeuchi K; Shiokoshi M; Takeda H; Miki M; Kumagai T; Nakanowatari S; Takahashi H; Utagawa M; Nishiya H; Kawakami S; Kobayashi N; Takasaki J; Mezaki K; Konosaki H; Aoki Y; Yamamoto Y; Shoji M; Goto H; Saraya T; Kurai D; Okazaki M; Niki Y; Yoshida K; Kawana A; Saionji K; Fujikura Y; Miyazawa N; Kudo M; Sato Y; Yamamoto M; Yoshida T; Nakamura M; Tsukada H; Imai Y; Tsukada A; Kawasaki S; Honma Y; Yamamoto T; Ban N; Mikamo H; Sawamura H; Miyara T; Toda H; Sato K; Nakamura T; Fujikawa Y; Mitsuno N; Mikasa K; Kasahara K; Sano R; Sugimoto K; Asari S; Nishi I; Toyokawa M; Miyashita N; Koguchi Y; Kusano N; Mihara E; Kuwabara M; Watanabe Y; Kawasaki Y; Takeda K; Tokuyasu H; Masui K; Negayama K; Hiramatsu K; Aoki Y; Fukuoka M; Magarifuchi H; Nagasawa Z; Suga M; Muranaka H; Morinaga Y; Honda J; Fujita M
    J Infect Chemother; 2015 Jun; 21(6):410-20. PubMed ID: 25817352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
    Werarak P; Kiratisin P; Thamlikitkul V
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.